# Bambusa Therapeutics

Type: Company

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/bambusa-therapeutics
Canonical HTML page: https://getstartupbrief.com/entity/bambusa-therapeutics

## Timeline

- **2026-03-19**: CFO Appointment — Bambusa Therapeutics officially announces Todd James as the new Chief Financial Officer.
- **2006**: Industry Tenure — Todd James builds 20+ years of experience in biopharmaceutical leadership and finance.

## Recent coverage (1 stories)

### Bambusa Therapeutics Names Biopharma Veteran Todd James as CFO
2026-03-19 14:26:07 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Bambusa Therapeutics has appointed Todd James, a biopharmaceutical industry veteran with over 20 years of experience, as its new Chief Financial Officer. The strategic hire signals a focus on strengthening capital markets expertise and investor relations as the company advances its therapeutic pipeline.
Full story: https://getstartupbrief.com/story/bambusa-therapeutics-appoints-todd-james-cfo

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.